WARS2 and movement disorder: The first cases with biallelic pathogenic variants in WARS2, described in 2017, had a predominant neurodevelopmental phenotype with developmental delay and intellectual disability, with only mild movement disorders such as tremor (OMIM: #617710) [3,4,5].